The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
ContributorsCsaki Huttner, Angela; Dayer, Julie-Anne; Yerly Ferrillo, Sabine; Combescure, Christophe
; Auderset, Floriane; Desmeules, Jules Alexandre; Eickmann, Markus; Finckh, Axel; Goncalves Cabecinhas, Ana Rita; Hooper, Jay W; Kaya, Guerkan; Krähling, Verena; Kwilas, Steve; Lemaitre, Barbara; Matthey, Alain; Silvera, Peter; Becker, Stephan; Fast, Patricia E; Moorthy, Vasee; Kieny, Marie Paule; Kaiser, Laurent; Siegrist, Claire-Anne

Published inLancet. Infectious diseases, vol. 15, no. 10, p. 1156-1166
Publication date2015
Abstract
Affiliation
- Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie
- Faculté de médecine / Section de médecine clinique / Département de pédiatrie, gynécologie et obstétrique
- Faculté de médecine / Section de médecine clinique / Département de santé et médecine communautaires
Citation (ISO format)
CSAKI HUTTNER, Angela et al. The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial. In: Lancet. Infectious diseases, 2015, vol. 15, n° 10, p. 1156–1166. doi: 10.1016/S1473-3099(15)00154-1
Main files (1)
Article (Published version)

Identifiers
- PID : unige:76362
- DOI : 10.1016/S1473-3099(15)00154-1
- PMID : 26248510
ISSN of the journal1473-3099